Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Laird Superfood, Inc. (LSF)
|
Add to portfolio |
|
|
Price: |
$13.95
| | Metrics |
OS: |
9.34
|
M
| |
-249
|
% ROE
|
Market cap: |
$130
|
M
| |
-640
|
% ROIC
|
Net cash:
|
$10.5
|
M
| |
$1.12
|
per share
|
EV:
|
$120
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
($27.6)
|
M
| |
|
|
EPS |
($4.14)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 35.8 | 35.8 | 36.8 | 36.8 | 25.8 | 13.1 | 8.3 |
Revenue growth | -2.7% | -2.7% | 42.8% | | 96.8% | 58.0% | |
Cost of goods sold | 30.6 | 6.4 | 27.4 | 8.4 | 15.6 | -5.0 | 5.6 |
Gross profit | 5.2 | 29.4 | 9.4 | 28.4 | 10.1 | 18.1 | 2.7 |
Gross margin | 14.5% | 82.1% | 25.6% | 77.2% | 39.3% | 138.4% | 32.1% |
Selling, general and administrative | | | | | | | 6.0 |
Sales and marketing | 14.5 | 6.9 | 15.9 | 7.6 | 17.0 | 13.5 | 2.6 |
Research and development | 0.4 | 0.4 | 1.0 | 1.0 | 1.7 | 0.6 | |
General and administrative | 44.8 | | 32.9 | | 14.5 | 8.8 | |
EBITA | -27.1 | -27.5 | -23.6 | -23.9 | -12.9 | -8.8 | -8.4 |
EBITA margin | -75.6% | -76.9% | -64.0% | -65.0% | -50.1% | -66.8% | -101.7% |
Amortization of intangibles | 0.4 | | 0.4 | | 0.0 | | |
EBIT | -27.5 | -27.5 | -23.9 | -23.9 | -12.9 | -8.8 | -8.4 |
EBIT margin | -76.9% | -76.9% | -65.0% | -65.0% | -50.1% | -66.8% | -101.7% |
Pre-tax income | -40.3 | -40.3 | -23.9 | -23.9 | -12.9 | -8.5 | -8.5 |
Income taxes | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.2 | 0.0 |
Tax rate | | | | | | | 0.0% |
Net income | -40.3 | -40.3 | -23.9 | -23.9 | -14.5 | -1.1 | -9.2 |
Net margin | -112.6% | -112.6% | -64.8% | -64.8% | -56.2% | -8.1% | -111.1% |
|
Diluted EPS | ($4.41) | ($4.41) | ($2.66) | ($2.66) | ($2.61) | ($0.29) | ($2.60) |
Shares outstanding (diluted) | 9.1 | 9.1 | 9.0 | 9.0 | 5.5 | 3.7 | 3.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|